Physician profile
Amit Gupta
NPI 1306266523
$1,236.21
in general payments reported to CMS, 2019-2025
10 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $97.76 · 2021: $119 · 2022: $144 · 2023: $510 · 2024: $242 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $875.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $233.64 | 2023 | |
| Janssen Pharmaceuticals, INC | $200.97 | 2021-2024 | Xarelto |
| Amgen INC. | $190.07 | 2023-2025 | Krystexxa, Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $180.56 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $113.87 | 2023 | Tremfya |
| Novartis Pharmaceuticals Corporation | $110.20 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $92.05 | 2022 | |
| Gilead Sciences, INC. | $84.53 | 2023 | Veklury |
| Mindray Ds USA, INC. | $15.22 | 2025 | A7 Anesthesia System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.10 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.